|Name of organisation||NHS Greater Glasgow & Clyde R&D|
|Annual prescriptions||17 million|
|Annual in patient visits||0.5 million|
|Annual out patient visits||1.32 million|
|R&D Director||Professor Julie Brittenden|
|Address||The Sackler Clinical Research Facility, 5th Floor, Neurosciences Building, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF|
|Telephone||0141 232 7600|
|Web||NHS Greater Glasgow and Clyde R&D|
This includes NHS Greater Glasgow and Clyde, NHS National Waiting Times, NHS Lanarkshire, NHS Ayrshire & Arran and NHS Dumfries and Galloway. It is managed by the R&D office in NHS Greater Glasgow and Clyde. The West node leads on the IT infrastructure for NRS by hosting the Scottish Research management Database (SReDa) and the National Databases Coordinator.
NHS Greater Glasgow & Clyde and the University of Glasgow founded Glasgow Biomedicine in 2004. Focussed at the heart of Western Europe's largest acute hospital, the Queen Elizabeth University Hospital and in partnership with other West of Scotland Health Boards and Universities, Glasgow Biomedicine supports clinical research by bringing together world-leading clinical academics and state-of-the-art facilities with access to an NHS patient base of 2.8 million (52% of the Scottish population).
We support our researchers and partners throughout the clinical research process with a range of services designed to ensure scientific integrity, fast approvals, effective governance, proactive project management and robust data management and reporting processes. Our support function also includes developing a 'fit for purpose' translational research infrastructure within the NHS. The partnership's research expertise includes world-class strength in Cardiovascular and Medical Sciences; Cancer; Infection, Immunity and Inflammation; Neuroscience and Psychology; Social Sciences and Health Economics; Paediatric Medicine. We have state-of-the-art research imaging capabilities including CT and 3TMRI which will be strengthened with the UK's only 7T MRI scanner in a clinical setting from 2016.
Support to researchers and partners is provided in every activity during the lifetime of a clinical research project:
- Regulatory submission – REC; MHRA; ARSAC
- Infrastructure support – CRF, Imaging, Safe Haven, Biorepository, CRF/Ecrf Design
- Trial master file set up
- Recruitment reporting
- Data entry
- Data queries
- SAE resolution
- Database lock
- Statistical analyses.
- Risk assessment
- Protocol development
- Analytical plan.
- Recruitment tracking
- Data collection
- Protocol amendment
- Trial monitoring
- IMP accountability
End of Trial
- Site close out
- End of trial
- IMP reconciliation
- TMF audit
Key R&D Contacts
|Clinical trials pharmacy||Samantha.firstname.lastname@example.org|
|Clinical Trials Unit||Sharon.email@example.com|